Forums. Last updated 15. . ASX - Short Term Trading. Just unfortunate to hit the black swan so badly here, both the. Charts. Latest Posts ForumsHalf Yearly Report and AccountsWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. IXC Price at posting: 37. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Market Cap $16. ASX - Day Trading. Zillow has 23383 homes for sale in British Columbia. ASX - By Stock. . Latest Posts. Cold Comfort Ice Cream Company, Victoria, British Columbia. Commodities. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. IXC (ASX) Ann: Trading Halt - HotCopper. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. ASX - By Stock. Created with Sketch. Folks say we are pioneers of craft ice cream in Victoria. Market . Created with Sketch. , page-17. 3¢. ASX - By Stock. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held. All IMO IXC Price at posting: 37. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Latest Posts. ASX - General. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. . Forums. 1. Join the HotCopper ASX share market forum today for free. Notification of cessation of securities - IXC. ASX - Day TradingCreated with Sketch. is 19. But since the cash holding is double the market cap, there most likely more upside than down side. ASX - By Stock. Market . Latest Posts. Created with Sketch. ASX - By Stock. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Forums. Notification of cessation of securities - IXC. . ASX - By Stock. 147,415. . Contrast that to data from Wales in 2017 which suggests that. Probably been disappointed like all of us Created with Sketch. Forums. ASX - General. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. ASX - By Stock. . Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. 0. Join the HotCopper ASX share market forum today for free. ASX - Short Term Trading. Results of MeetingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Very impressive. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Cannot wait. $100-200k might be the minimum for the market to take notice. Forums. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. Top Smart Score Stocks. Also took placement stock @$1. , page-3. 06KBNotification of cessation of securities - IXC. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. IXC needs to be proactive and release a statement. . The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. IXC “ presented “ about the AGM time to who ? If the company is aware ( as others seem to think) of an individual seller then they need to be proactive and take them out . Share “Exercise Price Subject to paragraph (j), the amount payable upon exercise of each Option will be the 50% premium to the 30 day VWAP immediately prior to the Meeting (Exercise Price). . ASX - By Stock. Currency in USD 38. 0. ASX - General. . ASX - Day Trading. , page-3. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. , page-3. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. IXC Price at posting: 44. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. ASX - Day TradingCreated with Sketch. Advertise on HotCopper. Created with Sketch. ASX - By Stock. Invex Receives Approval for Paediatric Plan from the EMA, page-2. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. ASX - Short Term Trading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 76 (-1. IXC Price at posting: $1. ASX - By Stock. Share "Online registration will open 30 minutes before the Meeting. ASX - By Stock. Join the HotCopper ASX share market forum today for free. . Very tempted to buy them back today at 19c. Latest Posts. 79 -0. Initial FDA and EMA Advice on Presendin Development, page-3. Created with Sketch. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. . ASX - By Stock. 40. Created with Sketch. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. ASX - By Stock. ASX - By Stock. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. ASX - Day TradingCreated with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC Valuation Report MST. is 19. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. $45M MC $30M Cash and a $1. 6 Upvote. Created with Sketch. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Created with Sketch. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. Proposed Capital Return to Shareholders of $14. Therefore Id bet the same bet with the same info again. Latest Posts. Market . Currency in USD 38. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Created with Sketch. . As thread states post your questions here and let’s start compiling a list. Join the HotCopper ASX share market forum today for free. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. Created with Sketch. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. Appreciate your input Dr T. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Market . ASX - By Stock. . Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). Created with Sketch. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. 147,415. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. , page-4. Created with Sketch. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. ASX - General. IXC. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Latest Posts. Forums. Slow and steady with IXC. ASX - By Stock. ASX - Day Trading. . IXC Price at posting: 79. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-9 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. **Close price adjusted for splits and dividend and/or capital gain distributions. . The announcement was certainly a setback but we're not dead in. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. ASX - By Stock. Created with Sketch. Created with Sketch. Transparency is our policy. IXC Valuation Report MST. ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. ASX - General. Below is the broker data for IXC November to. Created with Sketch. ASX - By Stock. . June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. Last updated 15. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. Issue of Tranche 1 Placement Shares and Appendix 2A. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. Market . Created with Sketch. Forex. Australian finance news, stock quotes, currency information and blogs0. , page-5. , page-4. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. . I think having this out we can discuss on the way. IXC Price at posting:. Charts. 7% #asx #ausbiz 23 Jun 2023 06:06:11. 8M ! Add to my watchlist. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. . 0. , page-6. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Last research or update on this I listened to was by FiftyOneCapital. 6% $DLM 50. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. AX stock on. IXC Valuation Report MST. Latest Posts. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. . 1950. ASX - Day Trading0. , page-4. Discover historical prices for IXC. ASX - By Stock. Charts. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. HotCopper has news, discussion, prices and market data on IXUP LIMITED. Last updated 15. Expand. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Last updated 10. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. A new thread to put trading comments / reasoning / opinions in. How many friends and family got out after the last announcementshould have been released at the same time, page-34. IXC Price at posting. Fully funded. . Share Would anyone know whether the 28c cash backing strips out all of the options listed in the notice? or is it included and they will fall away on strike dates?wonder if the GLP-1 agonist referred to in this media release. TRP also trades sub cash -5m i believe, haven't checked in a while. Created with Sketch. Charts. Friday we moved 55% off 690k volume. Forums. Sentiment for Invex Therapeutics Ltd. ASX - Day TradingCreated with Sketch. IXC Price at posting: 23. ASX - Day Trading. IXC Valuation Report MST. Created with. 79 -0. . I find this very intriguing and positive that in last few weeks about 1. 375,000. 5% last year. This was roughly 50/50 between lost wages and direct medical costs. In 2005, IIH cost the American health care. ASX - By Stock. . Australian finance news, stock quotes, currency information and blogs Active Funds. , page-35. 6% $DLM 50. More. Created with Sketch. 10 Upvote. , page-2. IXC (ASX) Ann: Trading Halt - HotCopper. , page-5. 91%) As of 03:35PM EST. **Close price adjusted for splits and dividend and/or capital gain distributions. 31% more bullish than other Healthcare sector stocks. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. . All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. 375,000. At that time the total costs of IIH exceeded $444,000,000. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN. gov and there is lots of good information about the trial. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. ASX - Day TradingHere's a very good opportunity for people in Sydney. 1950. 1950. 26 area could be wrong and it could go for example to $3. 026. My understanding is that NEU went from around $1. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Met primary endpoints for phase 2 trials. . 3¢. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. Created with Sketch. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. . Here come the vultures. Created with Sketch. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. ASX - By Stock. Market . 1950. . . . ASX - General. ASX - General. AX stock on Yahoo Finance. . Created with Sketch. Market . 5¢ Sentiment: Buy Disclosure: Held. . Target our investor community with our suite of Hotcopper Advertising opportunities. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. . . At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. IXC Valuation Report MST. . Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. Join the HotCopper ASX share market forum today for free. Market . They have acted appropriately. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. 64440. IXC Price at posting: 45. Forums. . 1. IXC Price at posting: 44. 8,369 likes · 140 talking about this · 1,407 were here. Most bio's get acquired on P2 readouts, if results are strong early here. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. , page-75. . All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. ASX - Day TradingAnother day…another approval. 30 Haven’t supported share price since then on market . More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Join the HotCopper ASX share market forum today for free. ASX - By Stock. 0. ASX - By Stock. ASX - By Stock. , page-5. Reply. 333334. ASX - Short Term Trading. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Forums. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. ASX - Day Trading. Report to HotCopper and itll be the end of it, cheers. Created with Sketch. .